[
    {
        "file_name": "IMMUNOMEDICSINC_08_07_2019-EX-10.1-PROMOTION AGREEMENT.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "1.91 \"Sales Representative\" means a sales representative used by Company to perform Details of the Product for the Initial Indication to Health Care Professionals in the Territory. Sales Representative shall not include any key account manager, medical science liaison or regional sales manager.",
                "changed_text": "1.91 \"Sales Representative\" means a marketing associate used by Company to perform Details of the Product for the Initial Indication to Health Care Professionals in the Territory. Sales Representative shall not include any key account manager, medical science liaison or regional sales manager.",
                "explanation": "The term \"Sales Representative\" is being redefined as \"Marketing Associate\", making it unclear if all sections using “Sales Representative” are actually referring to marketing associates or to the original definition of Sales Representative.",
                "location": "ARTICLE I DEFINITIONS"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "3.3 Sales Representatives.\n\n3.3.1 Qualifications. Company shall ensure that each Sales Representative: (i) is a full-time employee of Company and a full-time member of its sales force; (ii) possesses skills, training and experience that are consistent with industry standards applicable to the promotion of an oncological pharmaceutical product; (iii) has completed the Product-Specific Training and other sales training described in this Agreement and the Brand Plan and achieved a Passing Score on an examination in accordance with Section 2.2.2(c); and (iv) has become adequately equipped and knowledgeable with respect to the Product, as determined in accordance with Company's then-current standards for sales personnel selling pharmaceutical products in the Territory.",
                "changed_text": "3.3 Marketing Personnel.\n\n3.3.1 Qualifications. Company shall ensure that each Sales Representative: (i) is a full-time employee of Company and a full-time member of its sales force; (ii) possesses skills, training and experience that are consistent with industry standards applicable to the promotion of an oncological pharmaceutical product; (iii) has completed the Product-Specific Training and other sales training described in this Agreement and the Brand Plan and achieved a Passing Score on an examination in accordance with Section 2.2.2(c); and (iv) has become adequately equipped and knowledgeable with respect to the Product, as determined in accordance with Company's then-current standards for sales personnel selling pharmaceutical products in the Territory.",
                "explanation": "The term \"Sales Representatives\" is being redefined as \"Marketing Personnel\" in the section heading, which is contradicting with the actual name of the definition. This makes it unclear if all sections referencing back to “Sales Representative” are applicable to Marketing Personnel.",
                "location": "ARTICLE III PROMOTION"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "Company shall ensure that the Sales Representatives do not identify or represent themselves as employees or agents of Janssen or any Affiliate of Janssen.",
                "changed_text": "Company shall ensure that the Marketing Associates do not identify or represent themselves as employees or agents of Janssen or any Affiliate of Janssen.",
                "explanation": "The term \"Sales Representatives\" is being replaced with \"Marketing Associate\" which is contradicting with the actual definition of Sales Representatives, which makes it unclear that this section references to Marketing Associates or Sales Representatives.",
                "location": "3.3.5 Additional Obligations."
            }
        ]
    }
]